1 |
Acetylcysteine
| 3件: Acetylcysteine Acetylcysteine; Mucomyst; N-Acetylcysteine | 1件: D00221
D00221
| - | - | 21件: 6 6, 13, 19, 20, 21, 49, 51, 53, 58, 63, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337 |
2 |
Allogenic Donor CD362-enriched Human Umbilical Cord-derived Mesenchymal Stem Cells
| 1件: Orbcel-C Orbcel-C | - | - | - | 2件: 94 94, 95 |
3 |
Azathioprine
| 3件: AZATHIOPRINE AZATHIOPRINE; Azatioprina; Imuran | 1件: D00238
D00238
| - | - | 21件: 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 93, 94, 95, 96, 97, 162 |
4 |
Bezafibrate
| 1件: Bezafibrate Bezafibrate | 1件: D01366
D01366
| 1件: PPARA PPARA 💬 | 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 7件: 20 20, 93, 94, 160, 296, 316, 324 |
5 |
Budesonide
| 4件: BUDESONIDE BUDESONIDE; Entocort; Jorveza; Symbicort | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 9件: 66 66, 93, 94, 95, 96, 97, 98, 228, 299 |
6 |
Calcium
| 2件: Calcio Calcio; Calcium | - | - | - | 27件: 6 6, 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 156, 214, 215, 222, 224, 235, 265, 274, 298, 299 |
7 |
Cenicriviroc
| 1件: Cenicriviroc Cenicriviroc | 1件: D09878
D09878
| 2件: CCR2 CCR2, CCR5 💬 | 11件: Chemokine signaling pathway Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬 | 1件: 94 94 |
8 |
Cilofexor
| 1件: Cilofexor Cilofexor | - | - | - | 2件: 93 93, 94 |
9 |
Cladribine
| 4件: 2-CdA 2-CdA; CLADRIBINA; Cladribine; MAVENCLAD | 1件: D01370
D01370
| 1件: RRM1 RRM1 💬 | 6件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 3件: 11 11, 13, 94 |
10 |
Curcumin
| 1件: CURCUMIN CURCUMIN | - | - | - | 10件: 2 2, 13, 46, 67, 74, 94, 96, 97, 139, 299 |
11 |
Doconexent
| 2件: Docosahexaenoic acid Docosahexaenoic acid; Docosahexanoic Acid | - | - | - | 10件: 6 6, 46, 48, 49, 90, 94, 113, 240, 299, 301 |
12 |
Elafibranor
| 1件: Elafibranor Elafibranor | 1件: D11208
D11208
| 1件: PPARA PPARA 💬 | 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 2件: 93 93, 94 |
13 |
Erlotinib
| 1件: Erlotinib Erlotinib | 1件: D07907
D07907
| 1件: EGFR EGFR 💬 | 48件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis 💬 | 1件: 94 94 |
14 |
Fenofibrate
| 1件: Fenofibrate Fenofibrate | 1件: D00565
D00565
| 1件: PPARA PPARA 💬 | 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 6件: 8 8, 79, 93, 94, 97, 265 |
15 |
Hymecromone
| 1件: Hymecromone Hymecromone | 1件: D00170
D00170
| - | - | 1件: 94 94 |
16 |
Metronidazole
| 3件: Flagyl Flagyl; Metronidazol; Metronidazole | 1件: D00409
D00409
| - | - | 7件: 46 46, 51, 63, 94, 96, 97, 291 |
17 |
Minocycline
| 3件: Minocycline Minocycline; MINOCYCLINE HYDROCHLORIDE; Minomycin | 1件: D05045
D05045
| - | - | 14件: 2 2, 6, 8, 13, 46, 84, 85, 90, 94, 162, 201, 206, 280, 299 |
18 |
Mitomycin
| 2件: Mitomycin Mitomycin; Mitomycin C | 1件: D00208
D00208
| - | - | 3件: 94 94, 118, 329 |
19 |
Mizoribine
| 2件: BREDININ BREDININ; Mizoribine | 1件: D01392
D01392
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | 8件: 46 46, 49, 51, 53, 66, 94, 222, 224 |
20 |
norUrsodeoxycholic acid
| 2件: Norucholic acid Norucholic acid; NorUrsodeoxycholic Acid | - | - | - | 2件: 93 93, 94 |
21 |
Phenylbutyric acid
| 4件: 4-phenylbutyrate 4-phenylbutyrate; Pheburane; Phenylbutyrate; Sodium phenylbutyrate | - | - | - | 14件: 2 2, 3, 6, 8, 15, 21, 93, 94, 231, 244, 251, 297, 299, 338 |
22 |
PLN-74809
| 1件: PLN-74809 PLN-74809 | - | - | - | 2件: 85 85, 94 |
23 |
Potassium
| 1件: Potassium Potassium | 1件: D08403
D08403
| - | - | 13件: 36 36, 46, 66, 67, 88, 93, 94, 98, 115, 167, 179, 215, 235 |
24 |
Proline
| 1件: Proline Proline | 1件: D00035
D00035
| - | - | 2件: 94 94, 97 |
25 |
Rifaximin
| 3件: Rifaximin Rifaximin; RIFAXIMINA; Xifaxan | 1件: D02554
D02554
| - | - | 9件: 6 6, 65, 93, 94, 96, 97, 99, 296, 299 |
26 |
Rituximab
| 6件: MabThera MabThera; Rituxan; Rituximab; Rixathon; Ruxience; Truxima | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 48件: 11 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 |
27 |
Seladelpar
| 1件: SELADELPAR SELADELPAR | 1件: D11256
D11256
| 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 2件: 93 93, 94 |
28 |
Simtuzumab
| 2件: GS-6624 GS-6624; Simtuzumab | - | - | - | 2件: 85 85, 94 |
29 |
Simvastatin
| 3件: Simvastatin Simvastatin; Simvastatina; Simvastatine | 1件: D00434
D00434
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 21件: 6 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 |
30 |
Sulfasalazine
| 3件: Salazosulfapyridine Salazosulfapyridine; Salicylazosulfapyridine; Sulfasalazine | 1件: D00448
D00448
| - | - | 6件: 46 46, 86, 94, 107, 270, 271 |
31 |
Thalidomide
| 1件: Thalidomide Thalidomide | 1件: D00754
D00754
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 20件: 2 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 |
32 |
Tretinoin
| 5件: ATRA ATRA; Retinoic acid; Tretinoin; TRETINOINA; VESANOID | 1件: D00094
D00094
| 3件: PML PML, RARA, RARB 💬 | 12件: Acute myeloid leukemia Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | 6件: 2 2, 62, 63, 75, 94, 231 |
33 |
Ursodeoxycholic acid
| 4件: UDCA UDCA; Ursodeoxycholic Acid; Ursodiol; Ursofalk | 1件: D00734
D00734
| 1件: NR1H4 NR1H4 💬 | 1件: Bile secretion Bile secretion 💬 | 14件: 6 6, 8, 20, 46, 67, 84, 93, 94, 95, 96, 97, 234, 296, 299 |
34 |
Ursolic acid
| 1件: Ursolic acid Ursolic acid | - | - | - | 1件: 94 94 |
35 |
Vancomycin
| 1件: Vancomycin Vancomycin | 1件: D00212
D00212
| - | - | 8件: 13 13, 46, 70, 94, 96, 97, 296, 299 |
36 |
Vedolizumab
| 2件: ENTYVIO ENTYVIO; VEDOLIZUMAB | 1件: D08083
D08083
| 2件: ITGA4 ITGA4, ITGB7 💬 | 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 3件: 94 94, 96, 97 |
37 |
Vidofludimus
| 1件: Vidofludimus Vidofludimus | - | - | - | 5件: 13 13, 46, 94, 96, 97 |
38 |
Volixibat
| 1件: Volixibat Volixibat | 1件: D11007
D11007
| - | - | 2件: 93 93, 94 |
39 |
Zidovudine
| 3件: COMBIVIR COMBIVIR; Retrovir; Zidovudine | 1件: D00413
D00413
| - | - | 7件: 25 25, 26, 94, 135, 265, 325, 331 |